| Kézikönyv az Európai Unióról Z Horváth Magyar Országgyűlés, 2002 | 291 | 2002 |
| Grand unified schemes and spontaneous compactification Z Horvath, L Palla, E Cremmer, J Scherk Nuclear Physics B 127 (1), 57-65, 1977 | 241 | 1977 |
| Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors S Blencke, B Zech, O Engkvist, Z Greff, L Őrfi, Z Horváth, G Kéri, A Ullrich, ... Chemistry & biology 11 (5), 691-701, 2004 | 178 | 2004 |
| Small molecule inhibition of ERK dimerization prevents tumorigenesis by RAS-ERK pathway oncogenes A Herrero, A Pinto, P Colón-Bolea, B Casar, M Jones, L Agudo-Ibáñez, ... Cancer cell 28 (2), 170-182, 2015 | 157 | 2015 |
| Continuous synthesis of artemisinin-derived medicines K Gilmore, D Kopetzki, JW Lee, Z Horváth, DT McQuade, ... Chemical communications 50 (84), 12652-12655, 2014 | 157 | 2014 |
| A simple synthesis of 2-substituted oxazolines and oxazines A Cwik, Z Hell, A Hegedüs, Z Finta, Z Horváth Tetrahedron Letters 43 (22), 3985-3987, 2002 | 135 | 2002 |
| Feldspar: A domain specific language for digital signal processing algorithms E Axelsson, K Claessen, G Dévai, Z Horváth, K Keijzer, B Lyckegård, ... Eighth ACM/IEEE International Conference on Formal Methods and Models for …, 2010 | 127 | 2010 |
| Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling K Godl, OJ Gruss, J Eickhoff, J Wissing, S Blencke, M Weber, H Degen, ... Cancer Research 65 (15), 6919-6926, 2005 | 122 | 2005 |
| Genetic Variability of Central European Isolates of the Fusarium graminearum Species Complex B Tóth, Á Mesterházy, Z Horváth, T Bartók, M Varga, J Varga European Journal of Plant Pathology 113, 35-45, 2005 | 119 | 2005 |
| Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization? N Nagy, V Szűts, Z Horváth, G Seprényi, AS Farkas, K Acsai, J Prorok, ... Journal of molecular and cellular cardiology 47 (5), 656-663, 2009 | 116 | 2009 |
| Continuous synthesis and purification by direct coupling of a flow reactor with simulated moving-bed chromatography. AG O'Brien, Z Horváth, F Lévesque, JW Lee, A Seidel-Morgenstern, ... Angewandte Chemie (International ed. in English) 51 (28), 7028-7030, 2012 | 95 | 2012 |
| Handbook on the European Union Z Horváth, P Szűcs Hvg-Orac, 2007 | 86 | 2007 |
| A new family of SU (2) symmetric integrable sigma models J Balog, P Forgacs, Z Horvath, L Palla Physics Letters B 324 (3-4), 403-408, 1994 | 85 | 1994 |
| Small-molecule inhibitors of NADPH oxidase 4 G Borbély, I Szabadkai, Z Horváth, P Markó, Z Varga, N Breza, F Baska, ... Journal of medicinal chemistry 53 (18), 6758-6762, 2010 | 81 | 2010 |
| On the influence of extra dimensions on the homogeneous isotropic universe P Forgacs, Z Horvath General Relativity and Gravitation 11, 205-216, 1979 | 76 | 1979 |
| Human Electrophysiological and Pharmacological Properties of XEN-D0101: A Novel Atrial-Selective Kv1. 5/I: Kur: Inhibitor J Ford, J Milnes, E Wettwer, T Christ, M Rogers, K Sutton, D Madge, ... Journal of cardiovascular pharmacology 61 (5), 408-415, 2013 | 75 | 2013 |
| Biportal endoscopic management of third ventricle tumors in patients with occlusive hydrocephalus F Vetõ, Z Horváth, T Dóczi Neurosurgery 40 (4), 871-877, 1997 | 70 | 1997 |
| Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations L Bárándi, L Virág, N Jost, Z Horváth, I Koncz, R Papp, G Harmati, ... Basic research in cardiology 105, 315-323, 2010 | 68 | 2010 |
| Signal transduction therapy with rationally designed kinase inhibitors G Keri, L Orfi, D Eros, B Hegymegi-Barakonyi, C Szantai-Kis, Z Horvath, ... Current Signal Transduction Therapy 1 (1), 67-95, 2006 | 68 | 2006 |
| Topology and saddle points in field theories P Forgács, Z Horvath Physics Letters B 138 (5-6), 397-401, 1984 | 67 | 1984 |
Tamás KozsikDept. Programming Languages and Compilers, ELTE Eötvös Loránd University, Budapest, HungaryVerified email at elte.hu
